- Home
- EDIT vs HQI Comparison
EDIT vs HQI Comparison
Compare EDIT & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- HQI
- Stock Information
- Founded
- EDIT 2013
- HQI 2002
- Country
- EDIT United States
- HQI United States
- Employees
- EDIT N/A
- HQI N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- HQI Professional Services
- Sector
- EDIT Health Care
- HQI Consumer Discretionary
- Exchange
- EDIT Nasdaq
- HQI Nasdaq
- Market Cap
- EDIT 179.1M
- HQI 143.3M
- IPO Year
- EDIT 2016
- HQI N/A
- Fundamental
- Price
- EDIT $3.20
- HQI $10.24
- Analyst Decision
- EDIT Buy
- HQI Strong Buy
- Analyst Count
- EDIT 12
- HQI 2
- Target Price
- EDIT $6.20
- HQI $16.00
- AVG Volume (30 Days)
- EDIT 3.2M
- HQI 14.8K
- Earning Date
- EDIT 08-06-2025
- HQI 08-07-2025
- Dividend Yield
- EDIT N/A
- HQI 2.32%
- EPS Growth
- EDIT N/A
- HQI N/A
- EPS
- EDIT N/A
- HQI 0.24
- Revenue
- EDIT $35,837,000.00
- HQI $33,651,000.00
- Revenue This Year
- EDIT N/A
- HQI N/A
- Revenue Next Year
- EDIT N/A
- HQI $4.99
- P/E Ratio
- EDIT N/A
- HQI $42.69
- Revenue Growth
- EDIT N/A
- HQI N/A
- 52 Week Low
- EDIT $0.91
- HQI $9.04
- 52 Week High
- EDIT $6.05
- HQI $15.75
- Technical
- Relative Strength Index (RSI)
- EDIT 77.33
- HQI 53.03
- Support Level
- EDIT $2.48
- HQI $10.13
- Resistance Level
- EDIT $2.88
- HQI $10.38
- Average True Range (ATR)
- EDIT 0.26
- HQI 0.19
- MACD
- EDIT 0.07
- HQI 0.04
- Stochastic Oscillator
- EDIT 96.72
- HQI 72.33
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.